American Nano Silicon (ANNO) 10-K 7 Jan 15 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Sep. 30, 2014	Jan. 06, 2015	Mar. 31, 2014
Document and Entity Information
Entity Registrant Name	American Nano Silicon Technologies, Inc.
Document Type	10-K
Document Period End Date	30-Sep-14
Amendment Flag	FALSE
Entity Central Index Key	1415917
Current Fiscal Year End Date	-21
Entity Common Stock, Shares Outstanding		46,917,445
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Entity Incorporation, State Country Name	State of California
Entity Incorporation, Date of Incorporation	6-Sep-96
Entity Public Float			$1,615,873

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2014	Sep. 30, 2013
Current assets:
Cash and cash equivalents	$97,233	$75,901
Accounts receivable, net	577,303	338,312
Inventory, net of reserve	397,094	433,811
Advance payments	137,575	289,368
Prepaid expense and other receivables	136,235	66,042
Prepaid value-added tax	70,168	123,157
Total current assets	1,415,608	1,326,591
Property, plant and equipment, net	20,545,631	22,786,880
Other assets:
Land use rights, net	986,449	1,013,848
Total other assets	986,449	1,013,848
Total Assets	22,947,688	25,127,319
Current liabilities:
Accounts payable	234,686	187,605
Short term loans	10,096,451	5,345,800
Taxes payable	114,435	55,926
Due to related parties-current portion	3,165,014	5,500,997
Long term loans-current portion	1,508,465	2,438,187
Accrued expenses and other payables	1,136,888	1,042,734
Total current liabilities	16,255,939	14,571,249
Long-term liabilities
Long term loans	4,766,471	1,020,224
Due to related parties	0	1,415,868
Total long term liabilities	4,766,471	2,436,092
Total Liabilities	21,022,410	17,007,341
Commitment and Contingencies
Stockholders' Equity
Common stock, $0.0001 par value, 200,000,000 shares authorized; 46,917,445 shares issued and outstanding as of September 30, 2014 and 2013, respectively	4,692	4,692
Additional paid-in-capital	14,640,456	14,474,258
Accumulated other comprehensive income	2,297,685	2,291,219
Accumulated deficit	-15,017,555	-8,650,191
Total Stockholders' Equity	1,925,278	8,119,978
Total Liabilities and Stockholders' Equity	$22,947,688	$25,127,319

CONSOLIDATED_BALANCE_SHEETS_PA

CONSOLIDATED BALANCE SHEETS PARENTHETICAL (USD $)	Sep. 30, 2014	Sep. 30, 2013
CONSOLIDATED BALANCE SHEETS PARENTHETICAL
Common stock par value	$0.00	$0.00
Common stock shares authorized	200,000,000	200,000,000
Common stock shares issued	46,917,445	46,917,445
Common stock shares outstanding	46,917,445	46,917,445

CONSOLIDATED_STATEMENTS_OF_COM

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
Revenues	$1,763,076	$798,390
Cost of Goods Sold	3,187,251	2,108,917
Gross Loss	-1,424,175	-1,310,527
Operating Expenses
Research and development expense	97,887	55,698
Selling, general and administrative	1,175,504	1,368,670
Impairment of property, plant and equipment	0	3,422,352
Total operating expense	1,273,391	4,846,720
Loss from operations	-2,697,566	-6,157,247
Other Income( Expense)
Interest expense - related party	-433,820	-473,194
Interest expense, net	-3,281,848	-1,249,983
Change in fair value of derivative liabilities	0	363,958
Other income	46,011	229,346
Total other income(expense)	-3,669,657	-1,129,873
Loss Before Income Taxes	-6,367,223	-7,287,120
Provision(Credit) for Income Taxes	141	-115,026
Net Loss	-6,367,364	-7,172,094
Other Comprehensive Loss
Foreign currency translation adjustment	6,466	236,504
Comprehensive Loss	($6,360,898)	($6,935,590)
Income (loss) per common share - Basic and diluted	($0.14)	($0.18)
Weighted average number of common shares - Basic and diluted	46,917,445	39,407,719

CONSOLIDATED_STATEMENTS_OF_CHA

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (USD $)	Common stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	(Accumulated deficit) Retained Earnings	Total
Balance at Sep. 30, 2012	$3,906	$13,689,967	$2,054,715	($1,478,097)	$14,270,491
Balance - shares at Sep. 30, 2012	39,061,840
Common stock issued for loan settlement - related party	600	479,400			480,000
Common stock issued for loan settlement-related party - shares	6,000,000
Net Income (Loss)				-7,172,094	-7,172,094
Stock issued for penalty on stock purchase	186	-186
Stock issued for penalty on stock purchase - shares	1,855,605
Imputed interest expense for non interest bearing related party loans		305,077			305,077
Foreign currency translation adjustments			236,504		236,504
Balance at Sep. 30, 2013	4,692	14,474,258	2,291,219	-8,650,191	8,119,978
Balance - shares at Sep. 30, 2013	46,917,445
Net Income (Loss)				-6,367,364	-6,367,364
Imputed interest expense for non interest bearing related party loans		166,198			166,198
Foreign currency translation adjustments			6,466		6,466
Balance at Sep. 30, 2014	$4,692	$14,640,456	$2,297,685	($15,017,555)	$1,925,278
Balance - shares at Sep. 30, 2014	46,917,445

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash Flows From Operating Activities:
Net Income (Loss)	($6,367,364)	($7,172,094)
Adjustments to reconcile net loss to net cash used in operating activities:
Inventory markdown	3,865	54,218
Provision(recovery) for Bad debt	-38,274	37,671
Change in fair value of derivative liabilities	0	-363,958
Depreciation and amortization	1,494,180	1,459,405
Imputed interest expense for non interest bearing related party loans	166,198	305,077
Impairment of property, plant and equipment	0	3,422,352
Loss from disposal of property, plant and equipment	77,307	0
Changes in operating assets and liabilities:
(Increase) decrease in accounts receivable	-239,696	-321,845
(Increase) decrease in inventory	32,697	-233,937
(Increase) decrease in advance payments	151,967	-256,019
(Increase) decrease in prepaid expense and other receivables	-32,108	-78,735
(Increase) decrease in prepaid value-added tax	53,038	-69,850
Increase (decrease) in accounts payable	47,285	-218,309
Increase (decrease) in taxes payable	58,668	-117,386
Increase (decrease) in accrued expenses and other payables	94,886	606,887
Cash used in operating activities	-4,497,351	-2,946,523
Cash Flows From Investing Activities:
Proceeds from sale of property, plant and equipment	189,251	0
Additions to property and equipment	-314,411	-1,504,616
Cash used in investing activities	-125,160	-1,504,616
Cash Flows From Financing Activities
Proceeds (repayment) of related parties loans, net	-3,756,278	1,670,957
Proceeds from short term loans, net	5,578,258	2,203,873
Proceeds of long term loans, net	2,824,498	586,100
Cash provided by financing activities	4,646,478	4,460,930
Effect of exchange rate changes on cash and cash equivalents	-2,635	9,449
Increase in cash and cash equivalents	21,332	19,240
Cash and Cash Equivalents - Beginning of the year	75,901	56,661
Cash and Cash Equivalents - End of the year	97,233	75,901
During the period, cash was paid for the following:
Interest expense	3,226,399	1,194,691
Income tax	0	166
Non-cash investing and financing activities:
Common stock issued for loan settlement	$0	$480,000

Note_1_Organization_and_Basis_

Note 1 - Organization and Basis of Presentation	12 Months Ended
	Sep. 30, 2014
Notes
Note 1 - Organization and Basis of Presentation	Note 1 – ORGANIZATION AND BASIS OF PRESENTATION
	American Nano-Silicon Technologies, Inc. (the “Company” or “ANNO”) was incorporated in the State of California on September 6, 1996. Since 2006, the Company has been primarily engaged in the business of manufacturing and distributing refined consumer chemical products through its subsidiaries, Nanchong Chunfei Nano-Silicon Technologies Co., Ltd. (“Nanchong Chunfei”), Sichuan Chunfei Refined Chemicals Co., Ltd. (“Chunfei Chemicals”), and Sichuan Hedi Veterinary Medicines Co., Ltd. (“Hedi Medicines”).
	On August 26, 2006, ANNO, through its wholly owned subsidiary American Nano Silicon Technologies, Inc., a Delaware corporation (“ANST”), acquired a 95% interest in Nanchong Chunfei, a company incorporated in the People’s Republic of China (the “PRC” or “China”). Nanchong Chunfei directly owned 90% of Chunfei Chemicals, a Chinese corporation established under the laws of PRC on January 6, 2006. Chunfei Chemicals itself owned 92% of Hedi Medicines, also a Chinese company incorporated under the law of PRC on June 27, 2002.
	On September 6, 2011, the Company acquired all minority interests in its subsidiaries by agreeing to issue 1,650,636 shares of common stock to the minority interest holders. Thereafter, Nanchong Chunfei, Chunfei Chemicals, and Hedi Medicines became wholly owned subsidiaries of ANNO. The shares were issued to the minority interest holders on November 28, 2011.
	On May 28, 2013, the Company assigned 10% of the equity in Chunfei Chemicals to each of Mr. Fachun Pu, Mr. Qiwei Zhang and Mr. Jianbo Liu, and assigned 5% of the equity in Hedi Medicines to Mr. Fachun Pu, and the assignees paid to the Company cash equal to the registered equity amount.  At the same time, Messrs Pu, Zhang and Liu agreed to hold those equity interests solely for the benefit of the Company, to pay over to the Company any distributions or dividends they receive, to vote their interests as directed by the Company, and to resell the interests to the Company at its option for cash equal to the registered equity amount.
	The accompanying consolidated financial statements of the Company and its subsidiaries have been prepared in accordance with generally accepted accounting principles in the United States of America.
	Going Concern
	As shown in the accompanying consolidated financial statements, the Company had negative cash flows from operations for the year ended September 30, 2014 and the Company’s current liabilities exceed its current assets by $14.8 million 14800000at September 30, 2014. The Company suspended manufacturing operations in May 2011 as part of an effort to relocate the production facilities. The Company resumed limited production on January 2, 2012. The current cash and inventory level will not be sufficient to support the Company’s resumption of its normal operations and repayments of its loans. In addition, the Company has suffered negative cash flows for the past two years.  These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern.  The Company will need additional funds to meet its operating and financing obligations until sufficient cash flows are generated from anticipated production to sustain operations and to fund future development and financing obligations. We expect, but provide no assurance, that the affiliate companies owned by the Company’s largest shareholder and President, Mr. Pu Fachun, will continue providing necessary funding for the Company’s normal operations. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
	Reclassifications
	Certain amounts of prior period were reclassified for presentation purposes.

Note_2_Summary_of_Significant_

Note 2 - Summary of Significant Accounting Policies	12 Months Ended
	Sep. 30, 2014
Notes
Note 2 - Summary of Significant Accounting Policies	Note 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Principles of consolidation
	The consolidated financial statements represent the consolidated accounts of the Company and its subsidiaries, Nanchong Chunfei, Chunfei Chemicals and Hedi Medicines. All significant intercompany balances and transactions have been eliminated in the consolidation.
	Use of estimates
	In preparing the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, the management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Significant estimates required to be made by the management include, but are not limited to, the recoverability of long-lived assets and the valuation of inventories, valuation of warrant liabilities, the valuation of deferred tax assets, and fair value of other financial instruments. Actual results could differ from these estimates.
	Risks and uncertainties
	The operations of the Company are located in the PRC. Accordingly, the Company's business, financial condition, and results of operations may be influenced by the political, economic, and legal environments in the PRC, in addition to the general state of the PRC economy. The Company's results may be adversely affected by changes in the political and social conditions in the PRC, and by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things.
	Fair value of financial instruments
	The Company adopted the provisions of Accounting Standards Codification (“ASC”) 820, Fair Value Measurements and Disclosures. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:
	Level 1- Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.
	Level 2- Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.
	Level 3- Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.
	The carrying amounts reported in the balance sheets for cash, accounts receivable, prepaid expenses, other receivables, advance to suppliers, short-term loan, accounts payable, advance from customers, other payables and accrued expenses approximate their fair market value based on the short-term maturity of these instruments. The carrying value of the long-term debt approximates fair value based on market rates and terms currently available to the Company. The Company uses Level 3 method to measure fair value of its derivative warrant liability (see note 10). The Company did not identify any other assets or liabilities that are required to be presented on the consolidated balance sheets at fair value in accordance with ASC 820.
	Cash and cash equivalents
	Cash and cash equivalents include cash on hand and cash on deposit and all highly liquid debt instruments with an original maturity of three months or less.
	Accounts receivable
	The Company's policy is to maintain reserves for potential credit losses on accounts receivable. Provisions are made against accounts receivable to the extent which they are considered to be doubtful. Accounts receivable on the balance sheet are stated net of such provisions. These provisions are based on management’s analysis of customers’ credit history and current relationships with those customers. Based on this assessment, it has been concluded that realization losses on balances outstanding at year-end will be immaterial.
	Allowances for doubtful accounts receivable balances are recorded when circumstances indicate that collection is doubtful for particular accounts receivable. Management estimates such allowances based on historical evidence such as amounts that are subject to risk.
	Inventory
	Inventories consist of raw materials and packing supplies. Inventories are valued at the lower of cost or market with cost determined on a weighted average basis. Market value represents the estimated selling price in the ordinary course of business less the estimated costs necessary to complete the sale.
	Property, plant & equipment
	Property, plant and equipment are stated at cost. The cost of an asset is comprised of its purchase price and any directly attributable costs of bringing the asset to its present working condition and location for its intended use. Depreciation and amortization are calculated using the straight-line method over the following useful lives:
	Buildings and improvements	39 years
	Machinery, equipment and automobiles	5-10 years
	Construction in progress represents direct costs of construction or acquisition and design fees incurred for the Company’s new plant and equipment. Capitalization of these costs ceases and the construction in progress is transferred to plant and equipment when substantially all the activities necessary to prepare the assets for their intended use are completed. No depreciation is provided until it is completed and ready for its intended use.
	Expenditures for maintenance and repairs are charged to expense as incurred. Additions, renewals and betterments are capitalized.
	Impairment of long-lived assets
	In accordance with ASC 360, “Accounting for the Impairment or Disposal of Long-Lived Assets”, the Company periodically reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value. The Company recognized an impairment loss of $0 and $3,422,352 for the years ended September 30, 2014 and 2013, respectively.
	Advance payments
	Advance payments represent the payments made and recorded in advance for goods and services.  Advances were also made for the purchase of the materials and equipment for the Company’s construction in progress.
	Revenue recognition
	The Company recognizes revenue under the FASB Codification Topic 605 (“ASC Topic 605”). Revenue is recognized when all the following have occurred: persuasive evidence of arrangement with customers, products are delivered, fees are fixed and determinable and collection is reasonably assured.  Payments received before all of the relevant criteria for revenue recognition are satisfied are recorded as advance from customers.
	Shipping and handling
	Shipping and handling costs incurred for shipping of finished products to customers are included in selling expense and totaled $87,741 and $43,346 for the years ended September 30, 2014 and 2013, respectively.
	Taxation
	Income taxes
	The Company accounts for income tax under the provisions of ASC 740-10-25, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of the events that have been included in the financial statements or tax returns. Deferred income taxes are recognized for all significant temporary differences between tax and financial statements bases of assets and liabilities. Valuation allowances will also be established against net deferred tax assets when it is more likely than not that some portion or all of the deferred tax asset will not be realized.
	Uncertain tax positions
	During the course of business, there are certain transactions and calculations for which the ultimate tax determination is uncertain. We establish reserves for tax-related uncertainties based on estimates of whether, and the extent to which, additional taxes may be due. These reserves are established when we believe that certain positions might be challenged despite our belief that our tax return positions are fully supportable. We adjust these reserves in light of changing facts and circumstances, such as the outcome of a tax audit or changes in the tax law. The provision for income taxes includes the impact of reserve provisions and changes to reserves that are considered appropriate.
	Value added tax
	Value added tax is imposed on goods sold in or imported in the PRC. Value added tax payable in the People’s Republic of China is charged on an aggregated basis at a rate of 13% or 17% (depending on the type of goods involved) on the full price collected for the goods sold or, in the case of taxable services provided, at a rate of 17% on the charges for the taxable services provided, but excluding, in respect of both goods and services, any amount paid in respect of value added tax included in the price or charges, and less any deductible value added tax already paid by the taxpayer on purchases of goods and services in the same financial year. The Company had value added tax recoverable of $70,168 and $123,157 as of September 30, 2014 and 2013, respectively.
	Earnings (Loss) per share
	Earnings per share are calculated in accordance with the ASC 260, “Earnings per Share.” Basic net earnings per share are based upon the weighted average number of common shares outstanding, but excluding shares issued as compensation that have not yet vested. Diluted net earnings per share are based on the assumption that all dilutive convertible shares and stock options were converted or exercised, and that all unvested shares have vested. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.
	Statement of cash flows
	In accordance with ASC 230, cash flows from the Company’s operations are calculated based upon the local currencies. As a result, amounts related to assets and liabilities reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheet.
	Concentration of credit risk
	Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of advances to suppliers and other receivables arising from its normal business activities. The Company does not require collateral or other security to support these receivables.  The Company routinely assesses the financial strength of its debtors and, based upon factors surrounding the credit risk, establishes an allowance, if required, for uncollectible accounts.
	Foreign currency translation
	The Company’s principal country of operations is the PRC. The financial position and results of operations of the Company are determined using the local currency, Renminbi (“RMB”), as the functional currency. Foreign currency transactions are translated at the applicable rates of exchange in effect at the transaction dates. Monetary assets and liabilities denominated in foreign currencies at the balance sheet date are translated at the applicable rates of exchange in effect at that date. Revenues and expenses are translated at the average exchange rates in effect during the reporting period. Equity accounts are translated in the historical exchange rate when the transactions took place.
	RMB is not a fully convertible currency. All foreign exchange transactions involving RMB must take place either through the People’s Bank of China (the “PBOC”) or other institutions authorized to buy and sell foreign exchange. The exchange rates adopted for the foreign exchange transactions are the rates of exchange quoted by the PBOC, which are determined largely by supply and demand. Translation of amounts from RMB into US dollar has been made at the following exchange rates for the respective years:
	30-Sep-14
	Balance sheet	RMB 6.1534 to US$1.00
	Statement of operations and comprehensive loss	RMB 6.1400 to US$1.00
	30-Sep-13
	Balance sheet	RMB 6.1501 to US$1.00
	Statement of operations and comprehensive loss	RMB 6.2383 to US$1.00
	Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders' equity as "Accumulated Other Comprehensive Income".  Gains and losses resulting from foreign currency translations are included in Comprehensive Income (Loss).

Note_3_Inventory

Note 3 - Inventory	12 Months Ended
	Sep. 30, 2014
Notes
Note 3 - Inventory	Note 3 – INVENTORY
	The inventory consists of the following:
		September 30,		September 30,
		2013		2012
	Raw materials	$	125,338	$	128,669
	Packing supplies		70,126		40,393
	Work-in-process		75,199		60,032
	Finished goods		126,431		204,717
	Total	$	397,094	$	433,811
	The Company recorded inventory markdown allowance of $3,865 and $54,218 for the year ended September 30, 2014 and 2013 respectively.

Note_4_Property_Plant_and_Equi

Note 4 - Property, Plant and Equipment	12 Months Ended
	Sep. 30, 2014
Notes
Note 4 - Property, Plant and Equipment	Note 4–PROPERTY, PLANT AND EQUIPMENT
	The property, plant and equipment consisted of the following:
		September 30,				September 30,
		2014				2013
	Machinery & Equipment		$	9,854,564			$	9,255,914
	Plant & Buildings			16,217,990				16,226,794
	Sub total			26,072,554				25,482,708
	Less: Accumulated Depreciation			(5,616,396	)			(4,255,928	)
	Add: Construction in Process			89,473				1,560,100
	Property, Plant and Equipment		$	20,545,631			$	22,786,880
	Depreciation expense for the years ended September 30, 2014 and 2013 was $1,467,271 and $1,432,921, respectively.

Note_5_Related_Party_Transacti

Note 5 - Related Party Transactions	12 Months Ended
	Sep. 30, 2014
Notes
Note 5 - Related Party Transactions	NOTE 5 - RELATED PARTY TRANSACTIONS
	The Company periodically borrows money from its shareholders and other related parties to finance the operations.  The details of loans from shareholders and related parties are as follows:
		September 30,		September 30,
		2014		2013
	Short term:
	Short term loan from Sichuan Chunfei Real Estate	$	1,212,670		$	856,163
	Short term loan from Sichuan Chunfei Daily Chemical		755,759			364,723
	Short term loan from Mr. Pu Fachun		1,133,694			1,649,040
	Short-term loan to Sichuan Lamate Technology Co. Ltd.		-			2,614,811
	Short term loan from Sichuan Shubei Feed Co. Ltd.		62,891			16,260
		$	3,165,014		$	5,500,997
	Long term:
	Loan From Mr. Pu Fachun		-			1,415,868
		$	-		$	1,415,868
	Sichuan Chunfei Daily Chemicals Co. Ltd (“Daily Chemical”) and Sichuan Chunfei Real Estate (“Chunfei Real Estate”) are owned by Mr. Pu Fachun. Sichuan Shubei Feed Co. Ltd. is owned by Mr. Pu Xidi, son of Mr. Pu Fachun. Sichuan Lamate Technology Co., Ltd. is owned by Mr. Zhang Qiwei, a member of the Company’s Board of Directors.
	The long term loan from Mr. Pu Fachun is non interest bearing and due on December 31, 2014.
	The Company recorded imputed interest at 6% per annum and recorded $166,198 and $305,077 for non-interest bearing related party loans for the years ended September 30, 2014 and 2013, respectively.
	Interest expense for interest-bearing related party loans was $267,622 and $168,117 for the years ended September 30, 2014 and 2013, respectively.
	The following table summary related party loans with interest and non interest:
		Non			Bearing
		interest			interest from
		bearing			0.9%-4% per month
	Short term loan	$	1,239,249		$	1,925,765
	Long term loan		-			-
		$	1,239,249		$	1,925,765

Note_6_Land_Use_Right

Note 6 - Land Use Right	12 Months Ended
	Sep. 30, 2014
Notes
Note 6 - Land Use Right	NOTE 6 - LAND USE RIGHT
	All land in the People’s Republic of China is government owned and cannot be sold to any individual or company. However, the government grants the user a “land use right” (the Right) to use the land. The Company has the Right to use the land on which its facilities are located for 50 years and amortizes the Right on a straight-line basis over the period of 50 years. As of September 30, 2014 and 2013, intangible assets consisted of the following:
		September 30,				September 30,
		2014				2013
	Land use rights	$	1,201,539		$		1,202,191
	Less: accumulated amortization		(215,090	)			(188,343	)
		$	986,449		$		1,013,848
	The amortization expense for the years ended September 30, 2014 and 2013 was $26,909 and $26,485, respectively.

Note_7_Short_Term_and_Longterm

Note 7 - Short Term and Long-term Loans	12 Months Ended
	Sep. 30, 2014
Notes
Note 7 - Short Term and Long-term Loans	NOTE 7 – SHORT TERM AND LONG-TERM LOANS
	The short term and long-term loans include the following:
		30-Sep-14		30-Sep-13
	a) Loan payable to Nanchong City Bureau of Finance due on demand, fixed interest rate of 0.465% per month	$	650,047	$		650,400
	b) Loan payable to Nanchong Commercial Bank due on January 24, 2014, which was paid in full in January 2014, at fixed interest rate of 6.6% per annum, guaranteed by a third party		-			813,000
	c) Loan payable to Nanchong Commercial Bank, due on March 7, 2015 and  July 23, 2015, at a fixed interest rate of 6.9%, guaranteed by a third party		1,625,118			-
	d) Loan payable to Nanchong Commercial Bank due on July 1, 2014, at fixed interest rate of 6.6% per annum, guaranteed by third parties. The loan was paid in full on July 1, 2014.		-			813,000
	e) Loan payable to Bank of Communications due on July 1, 2014, at floating interest rate, Guaranteed by third parties, Mr. Fu Fachun, Zhang Xuchu and Feng Ting, Hedi Medicines.  The loan was paid in full on July 1, 2014		-		813,000
	f) Loan payable to Bank of Communications due on July 23, 2015, at a interest rate of 7.8% per annum and guaranteed by a third party and Mr. Pu, Chairman and CEO of the Company		812,559			-
	g) Individual loans from unrelated parties, which are due on demand and bearing a weighted average interest rate of 3.56% per month		7,008,727			2,256,400
	Total Short Term Loans	$	10,096,451	$		5,345,800
	a) Individual loans from unrelated parties, bearing a weighted average interest rate of 2.79% per month		1,462,094			3,358,411
	b) Individual loans from various investors, bearing interest of 12% per annum and due on July 1, 2015, as extended  (See note 11)		100,000			100,000
	c) Loan payable to Jialing Rural Credit Cooperative Union due on December 19, 2015 at a interest rate of 10.764% per annum, secured by Chunfei Chemical’s real property and Chunfei Real Estate’s real property		4,712,842			-
	Less: current portion of long term loans		-1,508,465			-2,438,187
	Total Long Term Loans	$	4,766,471	$		1,020,224
	The Company pledged its land use right and its building and equipment to a third party to secure the bank loans The Company recorded interest expense of $3,281,848 and $1,250,266 for the years ended September 30, 2014 and 2013, respectively.

Note_8_Income_Taxes

Note 8 - Income Taxes	12 Months Ended
	Sep. 30, 2014
Notes
Note 8 - Income Taxes	NOTE 8 – INCOME TAXES
	The Company’s subsidiaries are governed by the Income Tax Law of the People’s Republic of China, which mandates a corporate income tax rate of 25%.  Hedi Medicine has been taxed at a flat rate of 260 RMB per quarter since calendar year 2012.
	The following table reconciles the U.S. statutory rates to the Company's effective tax rate for the years ended September 30, 2014 and 2013:
		For the years ended September 30
		2014			2013
	US statutory income tax rate		35	%		35	%
	Non-taxable item in US		0	%		-2	%
	Change in valuation allowance - US		-35	%		-33	%
	China income tax statutory rate		25	%		25	%
	Change in valuation allowance - China		-25	%		-25	%
	Prior period tax adjustment		0	%		-1.6	%
	Effective rate		0	%		-1.6	%
	As of September 30, 2014 net operating loss carry forwards for United States and China income tax purposes amounted to $2.5 million$2,500,000 and $16.5 million$16,500,000, respectively, which may be available to reduce future years' taxable income. These carry forwards will expire, if not utilized, beginning in 2028 through 2034 for U.S tax purposes and 2019 through 2020 for China income tax purposes. Management believes that the realization in the U.S. of the benefits arising from these losses appear to be uncertain due to the Company's business operations being primarily conducted in China and foreign income not recognized in the United States for United States income tax purposes. It is also uncertain that it is more likely that not that the China business operation will have income taxable in China. Accordingly, the Company has provided a 100% valuation allowance as of September 30, 2014 and 2013, respectively for the temporary difference related to the loss carry-forwards.
	The following table reconciles the changes of deferred tax asset for the years ended September 30, 2014 and 2013:
		September 30,			September 30,
		2014			2013
	United States:
	Deferred tax asset from loss carry-forward-Beginning	$	855,292		$	836,543
	Addition: loss carry-forward		17,567			18,749
	Valuation allowance-Beginning		(855,292	)		(836,543	)
	Addition: Valuation allowance		(17,567	)		(18,749	)
	Deferred tax asset-net	$	-		$	-
	China:
	Deferred tax asset from loss carry-forward-Beginning	$	2,084,623		$	185,246
	Addition: loss carry-forward		1,579,258			1,899,377
	Valuation allowance-Beginning		(2,084,623	)		(185,246	)
	Addition: Valuation allowance		(1,579,258	)		(1,899,377	)
	Deferred tax asset-net	$	-		$	-
	The Company’s open tax years for its U.S. federal and state income tax returns are for the tax years after 2010. These tax returns are subject to examination by the tax authorities.

Note_9_Concentration_of_Risks

Note 9 - Concentration of Risks	12 Months Ended
	Sep. 30, 2014
Notes
Note 9 - Concentration of Risks	NOTE 9 – CONCENTRATION OF RISKS
	For the year ended September 30, 2013, two customers accounted for 64.8% and 13.4% of total sales.
	For the year ended September 30, 2014, two customers accounted for 61% and 16.8% of total sales.
	None of the customers mentioned above is a related party to the Company.

Note_10_Warrant_Liabilities

Note 10 - Warrant Liabilities	12 Months Ended
	Sep. 30, 2014
Notes
Note 10 - Warrant Liabilities	NOTE 10 – WARRANT LIABILITIES
	In March and June 2010, the Company issued 4,200,000 shares of common stock and Warrants to purchase 4,000,000 shares of Common Stock (Series B Warrants) to three accredited institutional funds and an accredited investor for $2,000,000.
	The Company concluded that the Series B Warrants should be treated as derivative liabilities because the warrants are entitled to a price adjustment provision to allow the exercise price to be reduced in the event the Company issues or sells any additional shares of common stock at a price per share less than the then-applicable exercise price or without consideration, which is typically referred to as a “down-round protection” or “anti-dilution” provision.  The Company uses Level 3 inputs to measure fair value of its warrant liability.
	The Company's warrant liability accounts were as follows:
	Opening balance	$	363,958
	Issued in the year ended September 30, 2013		-
	Change in warrant liabilities		-363,958
	Exercised in the year ended September 30, 2013		-
	Closing balance, September 30, 2013	$	-
	As of September 30, 2013, 4,000,000 warrants have expired and none were exercised.

Note_11_Stockholders_Equity

Note 11 - Stockholders' Equity	12 Months Ended
	Sep. 30, 2014
Notes
Note 11 - Stockholders' Equity	NOTE 11 – STOCKHOLDERS’ EQUITY
	On September 18, 2013, the Company issued six million 6000000shares of common stock to Mr.Pu Fachun, CEO of the Company, at a price of approximately $0.08 per share.  The shares were issued in satisfaction of loans from Mr. Pu Fachun.
	On September 13, 2013 the Company issued 1,855,605 shares of common stock to the investors in the private placement of securities completed in March and June of 2010.  The shares were issued in satisfaction of the Company’s obligation under the second paragraph of Section 6.14 of the Securities Purchase Agreement dated March 19, 2010, which obligation accrued as a result of the Company’s failure to realize $5 million in net post-tax income (as defined in that agreement) for the fiscal year ended September 30, 2011. No fair value is used because the issuance of stock is treated as reallocation of proceeds on the common stock issued on private placement.
	In connection with the arrangement to cause the shares to be issued, the investors agreed that the maturity date of the $100,000 loan (See note 7) that they made to the Company on May 1, 2011 was extended to July 1, 2015, with interest accruing in the interim at a rate of 12% per annum, payable quarterly.
	A: Earnings Per Share
	The following is a reconciliation of the basic and diluted earnings (loss) per share computations for the years ended September 30, 2014 and 2013:
		2014		2013
	Net income (loss) for basic and diluted earnings (loss) per share	$	-6,367,364	$	-7,172,094
	Weighted average shares used in basic and diluted computation		46,917,445		39,407,719
	Earnings (loss) per share: Basic and diluted	$	-0.14	$	-0.18
	B. Option exercise
	As of September 30, 2014 and 2013, there are no options outstanding.

Note_12_Commitments

Note 12 - Commitments	12 Months Ended
	Sep. 30, 2014
Notes
Note 12 - Commitments	NOTE 12– COMMITMENTS AND CONTINGENCIES
	Employment Agreements
	As of May 1, 2008, the Company entered into indefinite employment agreements with Pu Fachun and Zhang Changlong.  The agreements provide for an annual salary of $10,000 to Mr. Pu and an annual salary of $7,500 to Mr. Zhang.
	The agreements provides that the officers’ compensation will be reviewed by the Board of Directors not less frequently than annually, and may be adjusted upward at any time in the sole discretion of the Board of Directors. The officers will be eligible for bonus compensation to be awarded at such times and in such amounts as determined by the board in its sole discretion. The term of each agreement commenced on the effective date of May 1, 2008 and will continue until an event of termination under the agreement, including the following (i) the disability of the officer, (ii) upon the death of any officer, or (ii) upon thirty days’ written notice from either party.
	Remuneration of Directors
	The Board of Directors has agreed that it will compensate Mr. Robert Fanella upon commencement of his service and on each anniversary of his commencement date, with $10,000 cash plus $40,000 in the form of restricted shares of the Company’s common stock, calculated on the average closing price per share for the five (5) trading days preceding and including the date stock is issued. The Board will also compensate each of Mr. He Ping, Mr. Lü Shuming, and Mr. Liu Dechun upon commencement of his service and on each anniversary of his commencement date, with $5,000 in cash.
	Litigation
	During the 2013 fiscal year, Jian Zhou, a shareholder, commenced a legal action against American Nano Silicon Technologies, Inc.  Mr. Zhou alleges that he is entitled to 857,142 shares of American Nano common stock in connection with the acquisition of Nanchong Chunfei by American Nano in 2007.  In response to the allegation, American Nano has asserted that all of the shares to which Mr. Zhou was entitled were issued to him. The trial court has dismissed Mr. Zhou’s claim, and he has appealed the dismissal to the court of appeals.

Note_13_Subsequent_Event

Note 13 - Subsequent Event	12 Months Ended
	Sep. 30, 2014
Notes
Note 13 - Subsequent Event	NOTE 13 –SUBSEQUENT EVENT
	The Company has evaluated subsequent events for purposes of recognition or disclosure through the date these financial statements were issued.

Note_1_Organization_and_Basis_1

Note 1 - Organization and Basis of Presentation: Going Concern (Policies)	12 Months Ended
	Sep. 30, 2014
Policies
Going Concern	Going Concern
	As shown in the accompanying consolidated financial statements, the Company had negative cash flows from operations for the year ended September 30, 2014 and the Company’s current liabilities exceed its current assets by $14.8 million 14800000at September 30, 2014. The Company suspended manufacturing operations in May 2011 as part of an effort to relocate the production facilities. The Company resumed limited production on January 2, 2012. The current cash and inventory level will not be sufficient to support the Company’s resumption of its normal operations and repayments of its loans. In addition, the Company has suffered negative cash flows for the past two years.  These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern.  The Company will need additional funds to meet its operating and financing obligations until sufficient cash flows are generated from anticipated production to sustain operations and to fund future development and financing obligations. We expect, but provide no assurance, that the affiliate companies owned by the Company’s largest shareholder and President, Mr. Pu Fachun, will continue providing necessary funding for the Company’s normal operations. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Note_2_Summary_of_Significant_1

Note 2 - Summary of Significant Accounting Policies: Principles of Consolidation (Policies)	12 Months Ended
	Sep. 30, 2014
Policies
Principles of Consolidation	Principles of consolidation
	The consolidated financial statements represent the consolidated accounts of the Company and its subsidiaries, Nanchong Chunfei, Chunfei Chemicals and Hedi Medicines. All significant intercompany balances and transactions have been eliminated in the consolidation.

Note_2_Summary_of_Significant_2

Note 2 - Summary of Significant Accounting Policies: Use of Estimates (Policies)	12 Months Ended
	Sep. 30, 2014
Policies
Use of Estimates	Use of estimates
	In preparing the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, the management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Significant estimates required to be made by the management include, but are not limited to, the recoverability of long-lived assets and the valuation of inventories, valuation of warrant liabilities, the valuation of deferred tax assets, and fair value of other financial instruments. Actual results could differ from these estimates.

Note_2_Summary_of_Significant_3

Note 2 - Summary of Significant Accounting Policies: Risks and Uncertainties (Policies)	12 Months Ended
	Sep. 30, 2014
Policies
Risks and Uncertainties	Risks and uncertainties
	The operations of the Company are located in the PRC. Accordingly, the Company's business, financial condition, and results of operations may be influenced by the political, economic, and legal environments in the PRC, in addition to the general state of the PRC economy. The Company's results may be adversely affected by changes in the political and social conditions in the PRC, and by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things.

Note_2_Summary_of_Significant_4

Note 2 - Summary of Significant Accounting Policies: Fair Value of Financial Instruments (Policies)	12 Months Ended
	Sep. 30, 2014
Policies
Fair Value of Financial Instruments	Fair value of financial instruments
	The Company adopted the provisions of Accounting Standards Codification (“ASC”) 820, Fair Value Measurements and Disclosures. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:
	Level 1- Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.
	Level 2- Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.
	Level 3- Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.
	The carrying amounts reported in the balance sheets for cash, accounts receivable, prepaid expenses, other receivables, advance to suppliers, short-term loan, accounts payable, advance from customers, other payables and accrued expenses approximate their fair market value based on the short-term maturity of these instruments. The carrying value of the long-term debt approximates fair value based on market rates and terms currently available to the Company. The Company uses Level 3 method to measure fair value of its derivative warrant liability (see note 10). The Company did not identify any other assets or liabilities that are required to be presented on the consolidated balance sheets at fair value in accordance with ASC 820.

Note_2_Summary_of_Significant_5

Note 2 - Summary of Significant Accounting Policies: Cash (Policies)	12 Months Ended
	Sep. 30, 2014
Policies
Cash	Cash and cash equivalents
	Cash and cash equivalents include cash on hand and cash on deposit and all highly liquid debt instruments with an original maturity of three months or less.

Note_2_Summary_of_Significant_6

Note 2 - Summary of Significant Accounting Policies: Accounts Receivable (Policies)	12 Months Ended
	Sep. 30, 2014
Policies
Accounts Receivable	Accounts receivable
	The Company's policy is to maintain reserves for potential credit losses on accounts receivable. Provisions are made against accounts receivable to the extent which they are considered to be doubtful. Accounts receivable on the balance sheet are stated net of such provisions. These provisions are based on management’s analysis of customers’ credit history and current relationships with those customers. Based on this assessment, it has been concluded that realization losses on balances outstanding at year-end will be immaterial.
	Allowances for doubtful accounts receivable balances are recorded when circumstances indicate that collection is doubtful for particular accounts receivable. Management estimates such allowances based on historical evidence such as amounts that are subject to risk.

Note_2_Summary_of_Significant_7

Note 2 - Summary of Significant Accounting Policies: Inventory (Policies)	12 Months Ended
	Sep. 30, 2014
Policies
Inventory	Inventory
	Inventories consist of raw materials and packing supplies. Inventories are valued at the lower of cost or market with cost determined on a weighted average basis. Market value represents the estimated selling price in the ordinary course of business less the estimated costs necessary to complete the sale.

Note_2_Summary_of_Significant_8

Note 2 - Summary of Significant Accounting Policies: Property, Plant & Equipment (Policies)	12 Months Ended
	Sep. 30, 2014
Policies
Property, Plant & Equipment	Property, plant & equipment
	Property, plant and equipment are stated at cost. The cost of an asset is comprised of its purchase price and any directly attributable costs of bringing the asset to its present working condition and location for its intended use. Depreciation and amortization are calculated using the straight-line method over the following useful lives:
	Buildings and improvements	39 years
	Machinery, equipment and automobiles	5-10 years
	Construction in progress represents direct costs of construction or acquisition and design fees incurred for the Company’s new plant and equipment. Capitalization of these costs ceases and the construction in progress is transferred to plant and equipment when substantially all the activities necessary to prepare the assets for their intended use are completed. No depreciation is provided until it is completed and ready for its intended use.
	Expenditures for maintenance and repairs are charged to expense as incurred. Additions, renewals and betterments are capitalized.

Note_2_Summary_of_Significant_9

Note 2 - Summary of Significant Accounting Policies: Impairment of Long-lived Assets (Policies)	12 Months Ended
	Sep. 30, 2014
Policies
Impairment of Long-lived Assets	Impairment of long-lived assets
	In accordance with ASC 360, “Accounting for the Impairment or Disposal of Long-Lived Assets”, the Company periodically reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value. The Company recognized an impairment loss of $0 and $3,422,352 for the years ended September 30, 2014 and 2013, respectively.

Recovered_Sheet1

Note 2 - Summary of Significant Accounting Policies: Revenue Recognition (Policies)	12 Months Ended
	Sep. 30, 2014
Policies
Revenue Recognition	Revenue recognition
	The Company recognizes revenue under the FASB Codification Topic 605 (“ASC Topic 605”). Revenue is recognized when all the following have occurred: persuasive evidence of arrangement with customers, products are delivered, fees are fixed and determinable and collection is reasonably assured.  Payments received before all of the relevant criteria for revenue recognition are satisfied are recorded as advance from customers.

Recovered_Sheet2

Note 2 - Summary of Significant Accounting Policies: Shipping and Handling (Policies)	12 Months Ended
	Sep. 30, 2014
Policies
Shipping and Handling	Shipping and handling
	Shipping and handling costs incurred for shipping of finished products to customers are included in selling expense and totaled $87,741 and $43,346 for the years ended September 30, 2014 and 2013, respectively.

Recovered_Sheet3

Note 2 - Summary of Significant Accounting Policies: Income Taxes (Policies)	12 Months Ended
	Sep. 30, 2014
Policies
Income Taxes	Income taxes
	The Company accounts for income tax under the provisions of ASC 740-10-25, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of the events that have been included in the financial statements or tax returns. Deferred income taxes are recognized for all significant temporary differences between tax and financial statements bases of assets and liabilities. Valuation allowances will also be established against net deferred tax assets when it is more likely than not that some portion or all of the deferred tax asset will not be realized.

Recovered_Sheet4

Note 2 - Summary of Significant Accounting Policies: Uncertain Tax Positions (Policies)	12 Months Ended
	Sep. 30, 2014
Policies
Uncertain Tax Positions	Uncertain tax positions
	During the course of business, there are certain transactions and calculations for which the ultimate tax determination is uncertain. We establish reserves for tax-related uncertainties based on estimates of whether, and the extent to which, additional taxes may be due. These reserves are established when we believe that certain positions might be challenged despite our belief that our tax return positions are fully supportable. We adjust these reserves in light of changing facts and circumstances, such as the outcome of a tax audit or changes in the tax law. The provision for income taxes includes the impact of reserve provisions and changes to reserves that are considered appropriate.

Recovered_Sheet5

Note 2 - Summary of Significant Accounting Policies: Earnings (loss) Per Share (Policies)	12 Months Ended
	Sep. 30, 2014
Policies
Earnings (loss) Per Share	Earnings (Loss) per share
	Earnings per share are calculated in accordance with the ASC 260, “Earnings per Share.” Basic net earnings per share are based upon the weighted average number of common shares outstanding, but excluding shares issued as compensation that have not yet vested. Diluted net earnings per share are based on the assumption that all dilutive convertible shares and stock options were converted or exercised, and that all unvested shares have vested. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.

Recovered_Sheet6

Note 2 - Summary of Significant Accounting Policies: Concentration of Credit Risk (Policies)	12 Months Ended
	Sep. 30, 2014
Policies
Concentration of Credit Risk	Concentration of credit risk
	Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of advances to suppliers and other receivables arising from its normal business activities. The Company does not require collateral or other security to support these receivables.  The Company routinely assesses the financial strength of its debtors and, based upon factors surrounding the credit risk, establishes an allowance, if required, for uncollectible accounts.

Recovered_Sheet7

Note 2 - Summary of Significant Accounting Policies: Foreign Currency Translation (Policies)	12 Months Ended
	Sep. 30, 2014
Policies
Foreign Currency Translation	Foreign currency translation
	The Company’s principal country of operations is the PRC. The financial position and results of operations of the Company are determined using the local currency, Renminbi (“RMB”), as the functional currency. Foreign currency transactions are translated at the applicable rates of exchange in effect at the transaction dates. Monetary assets and liabilities denominated in foreign currencies at the balance sheet date are translated at the applicable rates of exchange in effect at that date. Revenues and expenses are translated at the average exchange rates in effect during the reporting period. Equity accounts are translated in the historical exchange rate when the transactions took place.
	RMB is not a fully convertible currency. All foreign exchange transactions involving RMB must take place either through the People’s Bank of China (the “PBOC”) or other institutions authorized to buy and sell foreign exchange. The exchange rates adopted for the foreign exchange transactions are the rates of exchange quoted by the PBOC, which are determined largely by supply and demand. Translation of amounts from RMB into US dollar has been made at the following exchange rates for the respective years:
	30-Sep-14
	Balance sheet	RMB 6.1534 to US$1.00
	Statement of operations and comprehensive loss	RMB 6.1400 to US$1.00
	30-Sep-13
	Balance sheet	RMB 6.1501 to US$1.00
	Statement of operations and comprehensive loss	RMB 6.2383 to US$1.00
	Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders' equity as "Accumulated Other Comprehensive Income".  Gains and losses resulting from foreign currency translations are included in Comprehensive Income (Loss).

Recovered_Sheet8

Note 2 - Summary of Significant Accounting Policies: Property, Plant & Equipment: Property Plant and Equipment Useful Life Textblock (Tables)	12 Months Ended
	Sep. 30, 2014
Tables/Schedules
Property Plant and Equipment Useful Life Textblock
	Buildings and improvements	39 years
	Machinery, equipment and automobiles	5-10 years

Note_3_Inventory_Schedule_of_I

Note 3 - Inventory: Schedule of Inventory, Current (Tables)	12 Months Ended
	Sep. 30, 2014
Tables/Schedules
Schedule of Inventory, Current
		September 30,		September 30,
		2013		2012
	Raw materials	$	125,338	$	128,669
	Packing supplies		70,126		40,393
	Work-in-process		75,199		60,032
	Finished goods		126,431		204,717
	Total	$	397,094	$	433,811

Note_4_Property_Plant_and_Equi1

Note 4 - Property, Plant and Equipment: Property, Plant and Equipment (Tables)	12 Months Ended
	Sep. 30, 2014
Tables/Schedules
Property, Plant and Equipment
		September 30,				September 30,
		2014				2013
	Machinery & Equipment		$	9,854,564			$	9,255,914
	Plant & Buildings			16,217,990				16,226,794
	Sub total			26,072,554				25,482,708
	Less: Accumulated Depreciation			(5,616,396	)			(4,255,928	)
	Add: Construction in Process			89,473				1,560,100
	Property, Plant and Equipment		$	20,545,631			$	22,786,880

Note_5_Related_Party_Transacti1

Note 5 - Related Party Transactions: Schedule of Related Party Transactions (Tables)	12 Months Ended
	Sep. 30, 2014
Tables/Schedules
Schedule of Related Party Transactions
		September 30,		September 30,
		2014		2013
	Short term:
	Short term loan from Sichuan Chunfei Real Estate	$	1,212,670		$	856,163
	Short term loan from Sichuan Chunfei Daily Chemical		755,759			364,723
	Short term loan from Mr. Pu Fachun		1,133,694			1,649,040
	Short-term loan to Sichuan Lamate Technology Co. Ltd.		-			2,614,811
	Short term loan from Sichuan Shubei Feed Co. Ltd.		62,891			16,260
		$	3,165,014		$	5,500,997
	Long term:
	Loan From Mr. Pu Fachun		-			1,415,868
		$	-		$	1,415,868

Note_5_Related_Party_Transacti2

Note 5 - Related Party Transactions: Schedule of Related Party Loans with Interest and Non Interest (Tables)	12 Months Ended
	Sep. 30, 2014
Tables/Schedules
Schedule of Related Party Loans with Interest and Non Interest
		Non		Bearing
		interest		interest from
		bearing		0.9%-4% per month
	Short term loan	$	1,239,249	$	1,925,765
	Long term loan		-		-
		$	1,239,249	$	1,925,765

Note_6_Land_Use_Right_Schedule

Note 6 - Land Use Right: Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Tables)	12 Months Ended
	Sep. 30, 2014
Tables/Schedules
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
		September 30,				September 30,
		2014				2013
	Land use rights	$	1,201,539		$		1,202,191
	Less: accumulated amortization		(215,090	)			(188,343	)
		$	986,449		$		1,013,848

Note_7_Short_Term_and_Longterm1

Note 7 - Short Term and Long-term Loans: Schedule Of Debt (Tables)	12 Months Ended
	Sep. 30, 2014
Tables/Schedules
Schedule Of Debt
		30-Sep-14		30-Sep-13
	a) Loan payable to Nanchong City Bureau of Finance due on demand, fixed interest rate of 0.465% per month	$	650,047	$		650,400
	b) Loan payable to Nanchong Commercial Bank due on January 24, 2014, which was paid in full in January 2014, at fixed interest rate of 6.6% per annum, guaranteed by a third party		-			813,000
	c) Loan payable to Nanchong Commercial Bank, due on March 7, 2015 and  July 23, 2015, at a fixed interest rate of 6.9%, guaranteed by a third party		1,625,118			-
	d) Loan payable to Nanchong Commercial Bank due on July 1, 2014, at fixed interest rate of 6.6% per annum, guaranteed by third parties. The loan was paid in full on July 1, 2014.		-			813,000
	e) Loan payable to Bank of Communications due on July 1, 2014, at floating interest rate, Guaranteed by third parties, Mr. Fu Fachun, Zhang Xuchu and Feng Ting, Hedi Medicines.  The loan was paid in full on July 1, 2014		-		813,000
	f) Loan payable to Bank of Communications due on July 23, 2015, at a interest rate of 7.8% per annum and guaranteed by a third party and Mr. Pu, Chairman and CEO of the Company		812,559			-
	g) Individual loans from unrelated parties, which are due on demand and bearing a weighted average interest rate of 3.56% per month		7,008,727			2,256,400
	Total Short Term Loans	$	10,096,451	$		5,345,800
	a) Individual loans from unrelated parties, bearing a weighted average interest rate of 2.79% per month		1,462,094			3,358,411
	b) Individual loans from various investors, bearing interest of 12% per annum and due on July 1, 2015, as extended  (See note 11)		100,000			100,000
	c) Loan payable to Jialing Rural Credit Cooperative Union due on December 19, 2015 at a interest rate of 10.764% per annum, secured by Chunfei Chemical’s real property and Chunfei Real Estate’s real property		4,712,842			-
	Less: current portion of long term loans		-1,508,465			-2,438,187
	Total Long Term Loans	$	4,766,471	$		1,020,224

Note_8_Income_Taxes_Schedule_o

Note 8 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Tables)	12 Months Ended
	Sep. 30, 2014
Tables/Schedules
Schedule of Effective Income Tax Rate Reconciliation
		For the years ended September 30
		2014			2013
	US statutory income tax rate		35	%		35	%
	Non-taxable item in US		0	%		-2	%
	Change in valuation allowance - US		-35	%		-33	%
	China income tax statutory rate		25	%		25	%
	Change in valuation allowance - China		-25	%		-25	%
	Prior period tax adjustment		0	%		-1.6	%
	Effective rate		0	%		-1.6	%

Note_8_Income_Taxes_Schedule_o1

Note 8 - Income Taxes: Schedule of changes in deferred tax asset (Tables)	12 Months Ended
	Sep. 30, 2014
Tables/Schedules
Schedule of changes in deferred tax asset
		September 30,			September 30,
		2014			2013
	United States:
	Deferred tax asset from loss carry-forward-Beginning	$	855,292		$	836,543
	Addition: loss carry-forward		17,567			18,749
	Valuation allowance-Beginning		(855,292	)		(836,543	)
	Addition: Valuation allowance		(17,567	)		(18,749	)
	Deferred tax asset-net	$	-		$	-
	China:
	Deferred tax asset from loss carry-forward-Beginning	$	2,084,623		$	185,246
	Addition: loss carry-forward		1,579,258			1,899,377
	Valuation allowance-Beginning		(2,084,623	)		(185,246	)
	Addition: Valuation allowance		(1,579,258	)		(1,899,377	)
	Deferred tax asset-net	$	-		$	-

Note_10_Warrant_Liabilities_Sc

Note 10 - Warrant Liabilities: Schedule of Stockholders' Equity Note, Warrants or Rights (Tables)	12 Months Ended
	Sep. 30, 2014
Tables/Schedules
Schedule of Stockholders' Equity Note, Warrants or Rights
	Opening balance	$	363,958
	Issued in the year ended September 30, 2013		-
	Change in warrant liabilities		-363,958
	Exercised in the year ended September 30, 2013		-
	Closing balance, September 30, 2013	$	-

Note_11_Stockholders_Equity_Sc

Note 11 - Stockholders' Equity: Schedule of Earnings Per Share, Basic and Diluted (Tables)	12 Months Ended
	Sep. 30, 2014
Tables/Schedules
Schedule of Earnings Per Share, Basic and Diluted
		2014		2013
	Net income (loss) for basic and diluted earnings (loss) per share	$	-6,367,364	$	-7,172,094
	Weighted average shares used in basic and diluted computation		46,917,445		39,407,719
	Earnings (loss) per share: Basic and diluted	$	-0.14	$	-0.18

Note_1_Organization_and_Basis_2

Note 1 - Organization and Basis of Presentation (Details)	12 Months Ended
	Sep. 30, 2014
Details
Entity Incorporation, State Country Name	State of California
Entity Incorporation, Date of Incorporation	6-Sep-96

Note_1_Organization_and_Basis_3

Note 1 - Organization and Basis of Presentation: Going Concern (Details) (USD $)	Sep. 30, 2014
Details
Working capital deficiency	$14,800,000

Recovered_Sheet9

Note 2 - Summary of Significant Accounting Policies: Property, Plant & Equipment: Property Plant and Equipment Useful Life Textblock (Details)	12 Months Ended
	Sep. 30, 2014
Building and Building Improvements
Property, Plant and Equipment, Useful Life	39 years
Machinery and Equipment | Minimum
Property, Plant and Equipment, Useful Life	5 years
Machinery and Equipment | Maximum
Property, Plant and Equipment, Useful Life	10 years

Recovered_Sheet10

Note 2 - Summary of Significant Accounting Policies: Impairment of Long-lived Assets (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Details
Impairment of property, plant and equipment	$0	$3,422,352

Recovered_Sheet11

Note 2 - Summary of Significant Accounting Policies: Shipping and Handling (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Details
Shipping, Handling and Transportation Costs	$87,741	$43,346

Recovered_Sheet12

Note 2 - Summary of Significant Accounting Policies (Details) (USD $)	Sep. 30, 2014	Sep. 30, 2013
Details
Value Added Tax Receivable	$70,168	$123,157

Note_3_Inventory_Schedule_of_I1

Note 3 - Inventory: Schedule of Inventory, Current (Details) (USD $)	Sep. 30, 2014	Sep. 30, 2013
Details
Inventory, Raw Materials, Gross	$125,338	$128,669
Inventory Packing Supplies	70,126	40,393
Inventory, Work in Process, Gross	75,199	60,032
Inventory, Finished Goods, Gross	126,431	204,717
Inventory, net of reserve	$397,094	$433,811

Note_3_Inventory_Details

Note 3 - Inventory (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Details
Inventory Markdown Allowance	$3,865	$54,218

Note_4_Property_Plant_and_Equi2

Note 4 - Property, Plant and Equipment: Property, Plant and Equipment (Details) (USD $)	Sep. 30, 2014	Sep. 30, 2013
Property, plant and equipment, net	$20,545,631	$22,786,880
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	-5,616,396	-4,255,928
Equipment
Property, plant and equipment, net	9,854,564	9,255,914
Building
Property, plant and equipment, net	16,217,990	16,226,794
Building and Building Improvements
Property, plant and equipment, net	26,072,554	25,482,708
Construction in Progress
Property, plant and equipment, net	$89,473	$1,560,100

Note_4_Property_Plant_and_Equi3

Note 4 - Property, Plant and Equipment (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Details
Depreciation	$1,467,271	$1,432,921

Note_5_Related_Party_Transacti3

Note 5 - Related Party Transactions: Schedule of Related Party Transactions (Details) (USD $)	Sep. 30, 2014	Sep. 30, 2013
Due to related parties-current portion	$3,165,014	$5,500,997
Due to related parties	0	1,415,868
Short term loan from Chunfei Real Estate
Due to related parties-current portion	1,212,670	856,163
Short term loan from Chunfei Daily Chemical
Due to related parties-current portion	755,759	364,723
Short term loan from Pu Fachun
Due to related parties-current portion	1,133,694	1,649,040
Short term loan from Lamate Technology Co Ltd
Due to related parties-current portion		2,614,811
Short term loan from Shubei Feed Co Ltd
Due to related parties-current portion	62,891	16,260
Loan From Pu Fachun
Due to related parties		$1,415,868

Note_5_Related_Party_Transacti4

Note 5 - Related Party Transactions (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Details
Imputed interest expense for non interest bearing related party loans	$166,198	$305,077
ImputedInterestExpenseForInterestBearingRelatedPartyLoans	$267,622	$168,117

Note_5_Related_Party_Transacti5

Note 5 - Related Party Transactions: Schedule of Related Party Loans with Interest and Non Interest (Details) (USD $)	Sep. 30, 2014
Details
Non Interest Bearing Short Term Loans	$1,239,249
Interest Bearing Short Term Loans	1,925,765
Total Non Interest Bearing Loans	1,239,249
Total Interest Bearing Loans	$1,925,765

Note_6_Land_Use_Right_Schedule1

Note 6 - Land Use Right: Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) (USD $)	Sep. 30, 2014	Sep. 30, 2013
Details
Finite-Lived Intangible Assets, Gross	$1,201,539	$1,202,191
Finite-Lived Intangible Assets, Accumulated Amortization	-215,090	-188,343
Land use rights, net	$986,449	$1,013,848

Note_6_Land_Use_Right_Details

Note 6 - Land Use Right (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Details
Amortization of Intangible Assets	$26,909	$26,485

Note_7_Short_Term_and_Longterm2

Note 7 - Short Term and Long-term Loans: Schedule Of Debt (Details) (USD $)	Sep. 30, 2014	Sep. 30, 2013
Short term loans	$10,096,451	$5,345,800
Long term loans	4,766,471	1,020,224
Long term loans-current portion	-1,508,465	-2,438,187
Short Term Loan A
Short term loans	650,047	650,400
Short Term Loan B
Short term loans		813,000
Short Term Loan C
Short term loans	1,625,118
Short Term Loan D
Short term loans		813,000
Short Term Loan E
Short term loans		813,000
Short Term Loan F
Short term loans	812,559
Short Term Loan G
Short term loans	7,008,727	2,256,400
Long Term Loan A
Long term loans	1,462,094	3,358,411
Long Term Loan B
Long term loans	100,000	100,000
Long Term Loan C
Long term loans	$4,712,842

Note_7_Short_Term_and_Longterm3

Note 7 - Short Term and Long-term Loans (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Details
Interest Expense, Other	$3,281,848	$1,250,266

Note_8_Income_Taxes_Schedule_o2

Note 8 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Details)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Details
US statutory income tax rate	35.00%	35.00%
Non-taxable item in US	0.00%	-2.00%
Change in valuation allowance - US	-35.00%	-33.00%
China income tax statutory rate	25.00%	25.00%
Change in valuation allowance - China	-25.00%	-25.00%
Prior period tax adjustment	0.00%	-1.60%
Effective rate	0.00%	-1.60%

Note_8_Income_Taxes_Details

Note 8 - Income Taxes (Details) (USD $)	Sep. 30, 2014
Operating Loss Carry forwards Valuation Allowance	100.00%
UNITED STATES
Operating Loss Carryforwards	2,500,000
CHINA
Operating Loss Carryforwards	16,500,000

Note_8_Income_Taxes_Schedule_o3

Note 8 - Income Taxes: Schedule of changes in deferred tax asset (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
UNITED STATES
Deferred Tax Assets, Net, Current	$855,292	$836,543
Deferred Tax Assets, Operating Loss Carryforwards	17,567	18,749
Deferred Tax Assets, Valuation Allowance, Current	-855,292	-836,543
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	-17,567	-18,749
CHINA
Deferred Tax Assets, Net, Current	2,084,623	185,246
Deferred Tax Assets, Operating Loss Carryforwards	1,579,258	1,899,377
Deferred Tax Assets, Valuation Allowance, Current	-2,084,623	-185,246
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	($1,579,258)	($1,899,377)

Note_9_Concentration_of_Risks_

Note 9 - Concentration of Risks (Details)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Details
Concentration Risk, Customer	two customers accounted for 61% and 16.8% of total sales	two customers accounted for 64.8% and 13.4% of total sales

Note_10_Warrant_Liabilities_De

Note 10 - Warrant Liabilities (Details) (USD $)	4 Months Ended
	Jun. 30, 2010	Sep. 30, 2014	Sep. 30, 2013
Details
Common stock shares issued	4,200,000	46,917,445	46,917,445
Warrants exercised	$4,000,000
Proceeds from Issuance of Common Stock	$2,000,000
Warrants Expired		4,000,000

Note_10_Warrant_Liabilities_Sc1

Note 10 - Warrant Liabilities: Schedule of Stockholders' Equity Note, Warrants or Rights (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Details
Derivative Liability, Noncurrent		$363,958
Change in warrant liabilities	($363,958)

Note_11_Stockholders_Equity_De

Note 11 - Stockholders' Equity (Details) (USD $)	Sep. 30, 2014	Sep. 30, 2013	Jun. 30, 2010
Common stock shares issued	46,917,445	46,917,445	4,200,000
Issuance 1
Common stock shares issued	6,000,000
Shares Issued, Price Per Share	0.08
Issuance 2
Common stock shares issued	1,855,605

Note_11_Stockholders_Equity_Sc1

Note 11 - Stockholders' Equity: Schedule of Earnings Per Share, Basic and Diluted (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Details
Net Income Loss Attributable To American Nano Silicon Technologies Inc	($6,367,364)	($7,172,094)
Weighted average number of common shares - Basic and diluted	46,917,445	39,407,719
Income (loss) per common share - Basic and diluted	($0.14)	($0.18)

Note_12_Commitments_Details

Note 12 - Commitments (Details) (USD $)	12 Months Ended
	Sep. 30, 2014
Director cash compensation - Fanella	$10,000	[1]
Director cash compensation	5,000	[2]
Mr. Pu
Salaries, Wages and Officers' Compensation	10,000
Mr. Zhang
Salaries, Wages and Officers' Compensation	$7,500
[1]	The Board of Directors has agreed that it will compensate Mr. Robert Fanella upon commencement of his service and on each anniversary of his commencement date, with $10,000 cash plus $40,000 in the form of restricted shares of the Company's common stock, calculated on the average closing price per share for the five (5) trading days preceding and including the date stock is issued
[2]	The Board will also compensate Mr. He Ping, Mr. LC< Shuming, and Mr. Liu Dechun upon commencement of his service and on each anniversary of his commencement date, with $5,000 in cash.